Melatonin for sleep: dosing, when to take it, and is it safe (2026).

Melatonin is available over the counter in Poland and is sold like a regular sleep supplement. The title of this article promises dosing, so it must be stated upfront: you will not find a scheme to copy for your own shelf here. The reason is not precautionary. The meta-analysis cited by most guides states something contrary to the popular thesis that less means better. Independent laboratory analysis of products shows that the hormone content in a tablet can deviate from the label by several hundred percent. Instead of a number to copy, you get a description of what has actually been measured: how significant the effect is, who has the strongest evidence, what evening light does to melatonin, and which drug interaction has been documented by measurement.

KEY INFORMATION
• A meta-analysis of 19 studies involving 1683 people showed a reduction in time to fall asleep by an average of 7.06 minutes and an increase in sleep duration by 8.25 minutes (Ferracioli-Oda, PLoS One, 2013).
• In the same study, trials with longer duration and higher doses produced a greater effect, not a smaller one. The popular thesis about the superiority of the lowest doses does not come from this meta-analysis.
• In the analysis of 31 products, the melatonin content ranged from 83% below to 478% above the label declaration (Erland and Saxena, J Clin Sleep Med, 2017).
• The documented interaction concerns fluvoxamine: when taken together, the area under the melatonin concentration curve was 17 times higher (Härtter, Clin Pharmacol Ther, 2000).
• The choice of supplement and dosage is up to the doctor or pharmacist, not the article.

What is melatonin and what does it do in the body?

Melatonin is a hormone secreted by the pineal gland in darkness. Its role is not to force sleep, but to convey information to the body about the time of day. High levels at night trigger processes that prepare the body for sleep and regeneration, while light inhibits this production.

Melatonin acts through two G protein-coupled receptors, designated as MT1 and MT2. Both have been described and classified in the official pharmacological nomenclature (Dubocovich i wsp., Pharmacological Reviews, 2010). This same work clarifies a difference that is usually overlooked in guides: melatonin is primarily a chronobiotic substance, meaning it shifts the biological clock, and only secondarily a substance that facilitates falling asleep.

This difference has practical consequences. A sleeping aid induces drowsiness regardless of the time. A chronobiotic substance works more effectively the better it aligns with the moment in the circadian cycle when the body itself begins to shift to night. This is where the rest of this article comes from: with melatonin, sensible questions concern the timing of intake and the situation in which the circadian rhythm is indeed disrupted, not just the size of the dose.

Why does this article not provide a dosing scheme?

Because it cannot be honestly derived from the available studies. Meta-analyses show that melatonin works and indicate how significant this effect is, but do not establish a single dose that is good for everyone. The relationship between dose size and outcome in the literature is the opposite of what guides repeat.

The most frequently repeated thesis is that doses above 1 mg do not provide any additional benefit and only increase side effects. The meta-analysis by Ferracioli-Oda and colleagues states the opposite: longer trials using higher doses showed greater an effect on reducing time to fall asleep and on increasing sleep duration (Ferracioli-Oda i wsp., PLoS One, 2013). The quality of sleep itself improved regardless of the dose. This does not mean that more is better. It means that the popular justification for the lowest doses has been added to this source.

Additionally, there is a purely practical problem. Since the declaration on the packaging can be detached from the actual content, the scheme given in milligrams describes the number on the label, not the amount of substance that enters the body. Therefore, a sensible order is the opposite of usual: first determine whether melatonin is suitable for your sleep problem, then discuss the product with your doctor or pharmacist. A comparison of the forms of the product is described in a separate text about extended-release melatonin and regular.

What did the meta-analysis of melatonin really show?

The effect is real, repeatable, and small. In the meta-analysis, 19 randomized studies with placebo were included, totaling 1683 participants with primary sleep disorders. Melatonin reduced the time to fall asleep by an average of 7.06 minutes and increased total sleep time by 8.25 minutes.

The authors also provided confidence intervals that are worth noting alongside the averages: for sleep onset time from 4.37 to 9.75 minutes, for sleep duration from 1.74 to 14.75 minutes. Overall sleep quality improved to a degree described by a standardized mean difference of 0.22. The authors conclude that the effect of melatonin is moderate and less than that of other medications used for insomnia, but it does not diminish over time.

A newer meta-analysis involving 12 randomized controlled trials reached a similar conclusion and clarified where the evidence is strongest: reduction of sleep onset time in primary insomnia, delayed sleep phase syndrome, and regulation of sleep-wake rhythm in blind individuals (Auld i wsp., Sleep Medicine Reviews, 2017). The authors of this work conclude with a direct call for large randomized studies, as the existing ones are too small to discuss a therapeutic regimen.

How much melatonin is really in a tablet?

Significantly less or significantly more than the label claims. The research team analyzed 31 commercially available products using high-performance liquid chromatography. The melatonin content ranged from 83% below the claim to 478% above it, and the variation between batches of the same product reached 465%.

Over 71% of the products did not fall within a 10% margin around the declared value. In eight of the studied products, serotonin was additionally detected, which was not listed on the label (Erland i Saxena, Journal of Clinical Sleep Medicine, 2017). The authors found no correlation between the size of the deviation and the manufacturer or the form of the product, so it is impossible to indicate a safe category of products.

This finding changes the entire discussion about dosing. If the content can be many times higher or lower than declared, then the debate about whether a smaller or larger dose is better concerns the label on the box, not the amount of hormone in the blood. The same problem applies to the forms that are most commonly purchased, described in the text about melatonin gummies. The practical conclusion is simple: choose a product whose manufacturer publishes test results for content, and treat the label on the packaging as a declaration, not as a measurement.

Komu melatonina pomaga najbardziej?

For individuals whose problem is a shifted or disrupted circadian rhythm, rather than just difficulty falling asleep. This is the common denominator of situations where the evidence is strongest: jet lag, delayed sleep phase syndrome, and sleep rhythm disorders in blind individuals.

The Cochrane review included ten randomized studies involving passengers, flight crews, and military personnel. In nine of them, melatonin taken close to the target bedtime at the arrival location reduced jet lag symptoms after flights across five or more time zones, and the authors identified it as clearly effective in preventing and alleviating this condition (Herxheimer i Petrie, Cochrane Database of Systematic Reviews, 2002). This same review noted that doses from 0.5 to 5 mg worked similarly, with the caveat that after the higher dose, participants fell asleep faster and slept better, and there was no further improvement above 5 mg. The European Food Safety Authority issued two separate opinions regarding melatonin: one on alleviating subjective symptoms of jet lag (EFSA, 2010), and the other on shortening the time needed to fall asleep (EFSA, 2011). Both concern statements placed on food packaging and are not therapeutic recommendations.

On the other hand, there are situations where melatonin is purchased without justification. Chronic primary insomnia has a better-documented first-line treatment in the form of cognitive-behavioral therapy. Insomnia associated with pain, chronic illness, anxiety, or depression requires treatment of the underlying cause, and melatonin can at best be an adjunct agreed upon with a doctor.

Does evening light impair the action of melatonin?

Yes, and to an extent that is not visible to the naked eye. In a study involving 116 healthy volunteers, melatonin secretion was compared in individuals exposed to room light and dim light for eight hours prior to bedtime.

Room light delayed the onset of melatonin secretion in 99% of participants and shortened the duration of secretion by about 90 minutes. Exposure to light during normal sleeping hours suppressed secretion by more than half in 85% of measurements (Gooley i wsp., Journal of Clinical Endocrinology and Metabolism, 2011). It is worth noting the condition of the experiment, as it is often shortened in guides to one hour before sleep: it referred to eight hours in the evening, not the last quarter-hour before going to bed.

The practical conclusion is uncomfortable but specific. Turning off the lights for a few minutes before sleep will not reverse the effect of a brightly lit evening. If you want supplementation to make any sense, dimming the apartment must start early, not at the moment you swallow the tablet.

Z jakimi lekami melatonina wchodzi w interakcje?

The best-documented interaction concerns fluvoxamine, an antidepressant from the SSRI group, which strongly inhibits the enzyme CYP1A2 responsible for the breakdown of melatonin. The effect was measured directly and is significant.

In a study involving five healthy volunteers, simultaneous administration of fluvoxamine increased the area under the melatonin concentration curve by 17 times, and the maximum concentration by 12 times (Härtter i wsp., Clinical Pharmacology and Therapeutics, 2000). A second study, this time without external melatonin administration, showed that fluvoxamine alone raises the nighttime concentration of melatonin produced by the body by 2.8 times, while citalopram does not have this effect (von Bahr i wsp., European Journal of Clinical Pharmacology, 2000). Both studies involved small groups, with five and seven participants.

The second signal comes from case reports collected during the Cochrane review. The authors noted reports suggesting that individuals with epilepsy and patients taking warfarin may suffer harm from melatonin, and highlighted both threads as requiring further investigation. This is not evidence from a randomized study, but it is a sufficient reason not to start supplementation independently in either of these situations.

Beyond these points, the evidence situation is much weaker than suggested by warning lists circulating on the internet. Melatonin is mentioned alongside blood pressure-lowering and immunosuppressive drugs, but the scale of these interactions has not been measured as it has been with fluvoxamine. If you are taking medications regularly, make the decision about supplementation with a doctor or pharmacist who knows your list of medications.

Can melatonin replace sleep hygiene?

No, it cannot, because it acts on a different piece of the puzzle. Melatonin shifts the biological clock, while irregular waking hours, evening light, and stimulation before sleep disrupt this clock faster than the supplement can correct it.

Regular sleep and wake times are the foundation upon which everything else relies. Without them, the rhythm of melatonin secretion has nothing to anchor to, and supplementation becomes a band-aid for lifestyle. Methods that can be implemented without resorting to pills are discussed in more detail in the text about insomnia in adults and ways to sleep without sleeping pills.

It's also worth knowing that melatonin is not the only studied pathway. In a randomized study involving 46 older adults with primary insomnia, magnesium supplementation over eight weeks improved insomnia severity scores, sleep efficiency, and time to fall asleep, while total sleep time did not differ significantly between groups (Abbasi i wsp., Journal of Research in Medical Sciences, 2012). Differences between forms of this element are discussed in a separate article about magnezie na stres i sen.

Frequently Asked Questions

How much melatonin should I take for sleep?

This article does not resolve and should not. Meta-analyses confirm a moderate effect of melatonin, but do not establish a single dose that is good for everyone, and studies with higher doses showed a greater effect, not a smaller one. Discuss the choice of supplement with your doctor or pharmacist.

How significant is the effect of melatonin on sleep?

In a meta-analysis of 19 studies involving 1683 people, melatonin reduced the time to fall asleep by an average of 7.06 minutes and increased sleep duration by 8.25 minutes compared to placebo. The authors described this effect as moderate and less than that of sleeping pills, but it did not diminish over time.

Does the melatonin content in the supplement match the label?

Often not. In the analysis of 31 products, the content ranged from 83% below to 478% above the declaration, and over 71% of products fell outside the 10% margin. Eight contained serotonin, which was not mentioned on the label. The variability did not depend on the manufacturer or form.

When does melatonin have the strongest evidence?

In cases of circadian rhythm disorders. In a Cochrane review, nine out of ten studies showed a reduction in jet lag symptoms after flights across five or more time zones, and a newer meta-analysis indicates a reduction in time to fall asleep in primary insomnia, delayed sleep phase syndrome, and rhythm regulation in blind individuals.

Does melatonin interact with medications?

The best-documented interaction concerns fluvoxamine, which inhibits the CYP1A2 enzyme. When taken together, the area under the melatonin concentration curve was 17 times higher, and the maximum concentration was 12 times higher. When taking medications regularly, discuss supplementation with your doctor or pharmacist.

Does evening light weaken the effect of melatonin?

Yes. Eight hours of room light before sleep delayed the onset of melatonin secretion in 99% of participants and shortened its secretion time by about 90 minutes. Light during normal sleeping hours suppressed secretion by more than half in 85% of measurements.

Sleep and recovery support products can be found in the category supplements.

This article is for informational and educational purposes and does not constitute medical advice. Before starting supplementation, consult your doctor, especially if you are taking medications regularly, are pregnant or breastfeeding, or have a chronic illness.

Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-11